Medical Incubator Japan
Overview
Medical Incubator Japan is a venture capital firm that invests in the medical and healthcare industry, including biotechs, pharmaceuticals, regenerative medicine, gene therapy, medical devices, and digital health technologies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Hoba Therapeutics | Dec 2023 | Series A | Lead |
| Heartseed Inc. | May 2023 | Series D | Co-investor |
| IgGenix | Feb 2023 | Series B | Co-investor |
| RegCell, Inc. | Sep 2026 | Series A | Co-investor |
| Cytospire Therapeutics | May 2026 | Series A | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Medical Incubator Japan based?
Medical Incubator Japan is headquartered in Tokyo, Japan.
When was Medical Incubator Japan founded?
Medical Incubator Japan was founded in 2015.
How many portfolio companies does Medical Incubator Japan have?
Medical Incubator Japan has 7 portfolio companies in Caplight's dataset.
What are some companies in Medical Incubator Japan's portfolio?
Portfolio companies visible on Caplight include Hoba Therapeutics, Heartseed Inc., IgGenix, RegCell, Inc., Cytospire Therapeutics.
What was Medical Incubator Japan's most recent investment shown here?
Medical Incubator Japan's most recent investment in this portfolio sample was in RegCell, Inc. in 2026.
What sectors does Medical Incubator Japan focus on?
Medical Incubator Japan focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Medical Incubator Japan focus on?
Medical Incubator Japan typically invests at the MultiStage stage.